The French pharmaceutical company Sanofi has confirmed that it aims to invest €1.3 billion ($1.4 billion) in the construction of a modern insulin production facility at its site near Frankfurt in western Germany. The new plant, with an area of around 36,000 square metres – around five football pitches – will replace a previous production facility on the site. Several hundred specialists are expected to be working there by 2029, the company said. “We are reaffirming our commitment to diabetes patients worldwide and utilizing the many years of expertise at our Frankfurt BioCampus with its highly…